{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:11:48Z","timestamp":1779275508027,"version":"3.51.4"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,31]]},"abstract":"<jats:p>\n                    Systemic immune-inflammation index (SII) integrates platelet, neutrophil, and lymphocyte counts (LYMPHs) and may reflect systemic inflammation and immune imbalance. Evidence on its prognostic value in type 2 diabetes mellitus (T2DM) remains limited. We investigated the association between SII and risks of all-cause and cardiovascular mortality in adults with T2DM. Data were derived from the National Health and Nutrition Examination Survey 1999 to 2018, including 6035 participants aged\u2005\u2265\u200520 years with T2DM. SII was calculated as platelet count\u2005\u00d7\u2005neutrophil count\/ LYMPH and analyzed as both a continuous and a categorical variable (quartiles). Kaplan\u2013Meier survival analysis, multivariable Cox proportional hazards models, and restricted cubic spline (RCS) analyses were performed to assess the association between SII levels and risks of all-cause and cardiovascular mortality. Subgroup analyses were performed to assess the robustness and consistency of the associations across different clinical strata. During a median follow-up of 82 months, 1808 (30.0%) of participants died from any cause and 780 (12.9%) from cardiovascular causes. All-cause cumulative mortality increased from 24.7% (Q1) to 37.6% (Q4); cardiovascular cumulative mortality from 10.9 to 16.4%. In fully adjusted models, each one-unit increase in SII was significantly associated with higher risks of all-cause mortality (HR\u2005=\u20051.15, 95% CI: 1.09\u20131.19,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001) and cardiovascular mortality (HR\u2005=\u20051.16, 95% CI: 1.09\u20131.22,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). Compared with Q1, participants in Q4 had a 48% higher risk of all-cause death (HR\u2005=\u20051.48, 95% CI: 1.30\u20131.70,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001) and a 41% higher risk of cardiovascular death (HR\u2005=\u20051.41, 95% CI: 1.15\u20131.72,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.001). RCS analysis suggested a nonlinear association, with mortality risks increasing steeply beyond an SII threshold of ~489. Exploratory subgroup findings showed no significant interactions. Elevated SII was significantly associated with higher risks of all-cause and cardiovascular mortality in patients with T2DM. These findings highlight the potential value of SII as a cost-effective and readily available biomarker for long-term risk stratification. However, given the observational nature of the study, causality cannot be inferred, and further prospective validation is warranted.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045452","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:01:39Z","timestamp":1763571699000},"page":"e45452","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Association between systemic immune inflammation index and mortality risks in type 2 diabetes based on NHANES"],"prefix":"10.1097","volume":"104","author":[{"given":"Cancan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daowen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6608-2252","authenticated-orcid":false,"given":"Kuanlu","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"Suppl 1","key":"R1-20260520","first-page":"S20","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2024.","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"R2-20260520","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3390\/ijms26031094","article-title":"Type 2 diabetes mellitus: new pathogenetic mechanisms, treatment and the most important complications.","volume":"26","author":"M\u0142ynarska","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R3-20260520","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","article-title":"Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants.","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"R4-20260520","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41569-023-00877-z","article-title":"Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention.","volume":"20","author":"Wong","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"R5-20260520","doi-asserted-by":"crossref","first-page":"e70003","DOI":"10.1002\/cph4.70003","article-title":"Type 2 diabetes mellitus: a comprehensive review of pathophysiology, comorbidities, and emerging therapies.","volume":"15","author":"Singh","year":"2025","journal-title":"Compr Physiol"},{"key":"R6-20260520","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1210\/endrev\/bnad030","article-title":"Protective factors and the pathogenesis of complications in diabetes.","volume":"45","author":"Yu","year":"2024","journal-title":"Endocr Rev"},{"key":"R7-20260520","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jare.2023.10.008","article-title":"\u03b2-Cell neogenesis: a rising star to rescue diabetes mellitus.","volume":"62","author":"Niu","year":"2024","journal-title":"J Adv Res"},{"key":"R8-20260520","doi-asserted-by":"crossref","first-page":"e70014","DOI":"10.1111\/1753-0407.70014","article-title":"Overview of oxidative stress and inflammation in diabetes.","volume":"16","author":"Weinberg Sibony","year":"2024","journal-title":"J Diabetes"},{"key":"R9-20260520","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s00011-024-01959-5","article-title":"Systemic immune inflammation index with all-cause and cause-specific mortality: a meta-analysis.","volume":"73","author":"Li","year":"2024","journal-title":"Inflamm Res"},{"key":"R10-20260520","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1007\/s10238-023-01035-y","article-title":"Systemic immune-inflammation index predicts prognosis and responsiveness to immunotherapy in cancer patients: a systematic review and meta-analysis.","volume":"23","author":"Kou","year":"2023","journal-title":"Clin Exp Med"},{"key":"R11-20260520","doi-asserted-by":"crossref","first-page":"1270368","DOI":"10.3389\/fmed.2023.1270368","article-title":"The association between systemic immune-inflammation index and chronic obstructive pulmonary disease in adults aged 40 years and above in the United States: a cross-sectional study based on the NHANES 2013\u20132020.","volume":"10","author":"Xu","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"R12-20260520","doi-asserted-by":"crossref","first-page":"1058779","DOI":"10.3389\/fimmu.2022.1058779","article-title":"Systemic immune-inflammation index is associated with hepatic steatosis: evidence from NHANES 2015\u20132018.","volume":"13","author":"Song","year":"2022","journal-title":"Front Immunol"},{"key":"R13-20260520","doi-asserted-by":"crossref","first-page":"1245199","DOI":"10.3389\/fendo.2023.1245199","article-title":"Association between systemic immune-inflammation index and diabetes: a population-based study from the NHANES.","volume":"14","author":"Nie","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R14-20260520","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.2147\/JIR.S454117","article-title":"Correlations between acute coronary syndrome and novel inflammatory markers (systemic immune-inflammation index, systemic inflammation response index, and aggregate index of systemic inflammation) in patients with and without diabetes or prediabetes.","volume":"17","author":"Tuzimek","year":"2024","journal-title":"J Inflamm Res"},{"key":"R15-20260520","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12933-025-02698-5","article-title":"Oxidative stress and inflammation mediate the adverse effects of cadmium exposure on all-cause and cause-specific mortality in patients with diabetes and prediabetes.","volume":"24","author":"Liu","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"R16-20260520","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1080\/07853890.2021.1991591","article-title":"Systemic immune-inflammation index is a promising non-invasive biomarker for predicting the survival of urinary system cancers: a systematic review and meta-analysis.","volume":"53","author":"Li","year":"2021","journal-title":"Ann Med"},{"key":"R17-20260520","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s13018-024-04808-7","article-title":"Association between the systemic immune-inflammation index and sarcopenia: a systematic review and meta-analysis.","volume":"19","author":"Xie","year":"2024","journal-title":"J Orthop Surg Res"},{"key":"R18-20260520","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11892-013-0375-y","article-title":"Diabetes mellitus and inflammation.","volume":"13","author":"Lontchi-Yimagou","year":"2013","journal-title":"Curr Diab Rep"},{"key":"R19-20260520","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.dsx.2019.01.040","article-title":"The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes).","volume":"13","author":"Halim","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"R20-20260520","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.kint.2022.10.030","article-title":"Targeting inflammation to treat diabetic kidney disease: the road to 2030.","volume":"103","author":"Rayego-Mateos","year":"2023","journal-title":"Kidney Int"},{"key":"R21-20260520","doi-asserted-by":"crossref","first-page":"1202463","DOI":"10.3389\/fendo.2023.1202463","article-title":"Diabetes-associated neutrophil NETosis: pathogenesis and interventional target of diabetic complications.","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R22-20260520","doi-asserted-by":"crossref","first-page":"e13940","DOI":"10.1111\/apha.13940","article-title":"Platelets and endothelial dysfunction in gestational diabetes mellitus.","volume":"237","author":"Valero","year":"2023","journal-title":"Acta Physiol (Oxf)"},{"key":"R23-20260520","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa2308743","article-title":"Teplizumab and \u03b2-cell function in newly diagnosed type 1 diabetes.","volume":"389","author":"Ramos","year":"2023","journal-title":"N Engl J Med"},{"key":"R24-20260520","doi-asserted-by":"crossref","first-page":"1377792","DOI":"10.3389\/fendo.2024.1377792","article-title":"Association of systemic immune-inflammation index with insulin resistance and prediabetes: a cross-sectional study.","volume":"15","author":"Guo","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R25-20260520","doi-asserted-by":"crossref","first-page":"bvae124","DOI":"10.1210\/jendso\/bvae124","article-title":"Association between systemic immune inflammation index and diabetes mellitus in the NHANES 2003\u20132018 population.","volume":"8","author":"Yan","year":"2024","journal-title":"J Endocr Soc"},{"key":"R26-20260520","first-page":"472","article-title":"Evaluation of systemic immune inflammation index and neutrophil-to-lymphocyte ratio in schizophrenia, bipolar disorder and depression.","volume":"125","author":"Canli","year":"2024","journal-title":"Bratisl Lek Listy"},{"key":"R27-20260520","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s13098-024-01536-0","article-title":"The systemic immune-inflammation index and systemic inflammation response index are useful for predicting mortality in patients with diabetic nephropathy.","volume":"16","author":"Zhang","year":"2024","journal-title":"Diabetol Metab Syndr"},{"key":"R28-20260520","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3390\/jcm13051256","article-title":"Systemic immune-inflammation index and systemic inflammatory response index as predictors of mortality in ST-elevation myocardial infarction.","volume":"13","author":"Marchi","year":"2024","journal-title":"J Clin Med"},{"key":"R29-20260520","doi-asserted-by":"crossref","first-page":"1425182","DOI":"10.3389\/fimmu.2024.1425182","article-title":"Commentary: association between systemic immune-inflammation index and psoriasis: a population-based study.","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"R30-20260520","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/tjem.tjem_198_23","article-title":"Unraveling the clinical significance and prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index, and delta neutrophil index: an extensive literature review.","volume":"24","author":"Islam","year":"2024","journal-title":"Turk J Emerg Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045452","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:02:43Z","timestamp":1779274963000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":30,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045452","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2025-07-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}